Drug Shortage Report for GEMCITABINE FOR INJECTION
Report ID | 1697 |
Drug Identification Number | 02305534 |
Brand name | GEMCITABINE FOR INJECTION |
Common or Proper name | GEMCITABINE |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GEMCITABINE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1000MG |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-11-01 |
Estimated end date | |
Actual end date | 2018-06-30 |
Shortage status | Resolved |
Updated date | 2020-02-13 |
Company comments | Product Discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-13 | French | Compare |
v3 | 2020-02-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 4 of 4